Cholecystokinin octapeptide regulates the differentiation and effector cytokine production of CD4+ T cells in vitro

International Immunopharmacology

Volumn 20, Issue 2, 2014, Pages 307-315

  Zhang, Jing Ge ^a   Liu, Jun Xu ^a   Jia, Xian Xian ^a   Geng, Jing ^a   Yu, Feng ^a   Cong, Bin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cholecystokinin; Signature cytokines; T helper cells; Transcription factors

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE; N (4 BROMOPHENYL) 3 OXO 4,5 DIPHENYL 1 PYRAZOLIDINECARBOXAMIDE; TRANSCRIPTION FACTOR FOXP3; 1-(4-BROMOPHENYLAMINOCARBONYL)-4,5-DIPHENYL-3-PYRAZOLIDINONE; ANTIINFLAMMATORY AGENT; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; PYRAZOLE DERIVATIVE;

ANIMAL CELL; ANTIGEN FUNCTION; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EFFECTOR CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DEVAZEPIDE; FORKHEAD TRANSCRIPTION FACTORS; IN VITRO TECHNIQUES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PYRAZOLES; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; SINCALIDE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84899005101     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.03.013     Document Type: Article

References (39)

1. J. Zhu, H. Yamane, and W.E. Paul Differentiation of effector CD4 T cell populations Annu Rev Immunol 28 2010 445 489
2. C. Holscher The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases Med Microbiol Immunol 193 2004 1 17
3. K.L. Knutson, and M.L. Disis Tumor antigen-specific T helper cells in cancer immunity and immunotherapy Cancer Immunol Immunother 54 2005 721 728
4. P.L. Ngoc, D.R. Gold, A.O. Tzianabos, S.T. Weiss, and J.C. Celedon Cytokines, allergy, and asthma Curr Opin Allergy Clin Immunol 5 2005 161 166
5. E. Bettelli, M. Oukka, and V.K. Kuchroo TH-17 cells in the circle of immunity and autoimmunity Nat Immunol 8 2007 345 350
6. L. Steinman A brief history of TH-17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage Nat Med 13 2007 139 145
7. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, and J.D. Sedgwick et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 2005 233 240
8. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 2005 1123 1132
9. H. Park, Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, and Y.H. Wang et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 2005 1133 1141
10. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, and M. Oukka et al. Reciprocal developmental pathways for the generation of pathogenic effector TH-17 and regulatory T cells Nature 441 2006 235 238
11. M. Veldhoen, R.J. Hocking, R.A. Flavell, and B. Stockinger Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease Nat Immunol 7 2006 1151 1156
12. P.R. Mangan, L.E. Harrington, D.B. O'Quinn, W.S. Helms, D.C. Bullard, and C.O. Elson et al. Transforming growth factor-beta induces development of the TH-17 lineage Nature 441 2006 231 234
13. T.S. Davidson, R.J. DiPaolo, J. Andersson, and E.M. Shevach Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3 + T regulatory cells J Immunol 178 2007 4022 4026
14. + natural regulatory T cells in dominant self-tolerance and autoimmune disease Immunol Rev 212 2006 8 27
15. Anne O'Garra, Leona Gabryšová, and Hergen Spits Quantitative events determine the differentiation and function of helper T cells Nat Immunol 12 2011 288 294
16. K.M. Murphy, and B. Stockinger Effector T cell plasticity: flexibility in the face of changing circumstances Nat Immunol 11 2010 674 680
17. Y.Y. Wan Multi-tasking of helper T cells Immunology 130 2010 166 171
18. + T cells Science 327 2010 1098 1102
19. J. Zhu, and W.E. Paul Heterogeneity and plasticity of T helper cells Cell Res 20 2010 4 12
20. J.N. Crawley, and R.L. Corwin Biological actions of cholecystokinin Peptides 15 1994 731 755
21. S. Miyamoto, K. Shikata, K. Miyasaka, S. Okada, M. Sasaki, and R. Kodera et al. Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin Diabetes 61 2012 897 907
22. M.D. Luyer, J.W. Greve, M. Hadfoune, J.A. Jacobs, C.H. Dejong, and W.A. Buurman Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve J Exp Med 202 2005 1023 1029
23. + T lymphocytes during small intestinal inflammation Gut 55 2006 492 497
24. S. Li, Z. Ni, B. Cong, W. Gao, S. Xu, and C. Wang et al. CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway Shock 27 2007 678 686
25. J.G. Zhang, B. Cong, Q.X. Li, H.Y. Chen, J. Qin, and L.H. Fu Cholecystokinin octapeptide regulates lipopolysaccharide-activated B cells co-stimulatory molecule expression and cytokines production in vitro Immunopharmacol Immunotoxicol 33 2011 157 163
26. J.G. Zhang, B. Cong, X.X. Jia, H. Li, Q.X. Li, and C.H. Ma et al. Cholecystokinin octapeptide inhibits immunoglobulin G1 production of lipopolysaccharide-activated B cells Int Immunopharmacol 11 2011 1685 1690
27. N. Song, S. Li, B. Cong, C. Wei, J. Cong, and F. Zhang et al. Cholecystokinin octapeptide modulates T lymphocyte subsets in KLH-immunized mice Chin J Pathophysiol 23 2007 423 427
28. Q. Li, D. Han, B. Cong, B. Shan, J. Zhang, and H. Chen et al. Cholecystokinin octapeptide significantly suppresses collagen-induced arthritis in mice by inhibiting Th17 polarization primed by dendritic cells Cell Immunol 272 2011 53 60
29. S. Sakaguchi Regulatory T, cells: key controllers of immunologic self-tolerance Cell 101 2000 455 458
30. K.M. Elias, A. Laurence, T.S. Davidson, G. Stephens, Y. Kanno, and E.M. Shevach et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway Blood 111 2008 1013 1020
31. E. Bettelli, M. Oukka, and V.K. Kuchroo T(H)-17 cells in the circle of immunity and autoimmunity Nat Immunol 8 2007 345 350
32. Y. Belkaid Regulatory T, cells and infection: a dangerous necessity Nat Rev Immunol 7 2007 875 888
33. J.A. Bluestone Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol 5 2005 343 349
34. S. Jiang Adoptive cell therapy using regulatory T cells as individualized medicine to promote clinical transplantation tolerance Discov Med 6 2006 239 242
35. + T-cell differentiation regulated by networks of cytokines and transcription factors Immunol Rev 238 2010 247 262
36. S.J. Szabo, B.M. Sullivan, C. Stemmann, A.R. Satoskar, B.P. Sleckman, and L.H. Glimcher Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells Science 295 2002 338 342
37. I.A. Ferber, H.J. Lee, F. Zonin, V. Heath, A. Mui, and N. Arai et al. GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels Clin Immunol 91 1999 134 144
38. W. Ouyang, S.H. Ranganath, K. Weindel, D. Bhattacharya, T.L. Murphy, and W.C. Sha et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism Immunity 9 1998 745 755
39. L. Zhou, J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, and G.D. Victora et al. TGF-beta-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORgammat function Nature 453 2008 236 240